News

It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has ...
In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...
BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...
Globus Medical GMED continues to gain from surging demand for its Musculoskeletal Solutions products. However, a challenging macroeconomic scenario continues to plague Globus Medical. The stock ...
In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...
GMED recently completed its previously disclosed acquisition of Nevro Corp., a global medical device company that delivers ...
Globus Medical (NYSE:GMED) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments ...